| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 133.310.843 | 167.792.153 | 210.409.826 | 199.654.955 | 252.064.926 | 253.889.446 | 304.742.724 | 331.670.009 | 186.466.789 | 1.564.144 |
| Total Income - EUR | 134.154.189 | 169.147.164 | 211.566.323 | 202.115.946 | 253.482.123 | 254.799.119 | 305.753.171 | 332.680.621 | 187.210.545 | 2.407.427 |
| Total Expenses - EUR | 133.930.689 | 168.128.940 | 210.225.019 | 204.858.888 | 255.068.450 | 255.455.599 | 306.253.550 | 334.084.989 | 193.340.433 | 2.201.037 |
| Gross Profit/Loss - EUR | 223.501 | 1.018.224 | 1.341.304 | -2.742.942 | -1.586.327 | -656.480 | -500.380 | -1.404.368 | -6.129.888 | 206.389 |
| Net Profit/Loss - EUR | 223.501 | 1.018.224 | 1.206.826 | -2.742.942 | -1.586.327 | -656.480 | -500.380 | -1.404.368 | -6.129.888 | 178.741 |
| Employees | 422 | 468 | 489 | 485 | 502 | 469 | 443 | 414 | 261 | 1 |
Check the financial reports for the company - Pharmafarm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.628.099 | 3.826.196 | 5.193.796 | 3.886.785 | 3.260.143 | 3.386.838 | 3.491.316 | 2.858.658 | 791.087 | 194.096 |
| Current Assets | 81.009.473 | 89.096.907 | 96.863.502 | 102.783.200 | 123.766.952 | 120.291.184 | 129.237.770 | 145.657.306 | 35.320.715 | 6.660.175 |
| Inventories | 20.823.065 | 25.757.482 | 28.617.787 | 25.766.845 | 26.111.224 | 23.918.072 | 19.532.770 | 22.663.264 | 1.939.894 | 10.340 |
| Receivables | 49.207.322 | 53.700.979 | 63.622.789 | 75.855.979 | 97.280.733 | 95.559.626 | 108.503.381 | 121.345.309 | 30.641.914 | 5.472.729 |
| Cash | 10.979.086 | 9.638.445 | 4.622.926 | 1.160.375 | 374.995 | 813.486 | 1.201.619 | 1.648.733 | 2.738.908 | 1.177.106 |
| Shareholders Funds | 4.908.314 | 20.152.588 | 21.987.782 | 18.257.421 | 16.317.519 | 15.450.141 | 14.607.140 | 13.248.091 | 6.464.655 | 6.607.266 |
| Social Capital | 21.963.700 | 36.015.809 | 35.406.360 | 34.756.590 | 34.083.490 | 33.437.347 | 32.695.842 | 32.797.281 | 32.697.825 | 32.515.086 |
| Debts | 78.366.800 | 71.729.086 | 79.254.610 | 87.745.356 | 109.774.976 | 107.428.401 | 116.875.425 | 134.602.652 | 29.254.581 | 163.788 |
| Income in Advance | 0 | 0 | 0 | 0 | 51.089 | 66.848 | 766.375 | 52.970 | 22.238 | 20.103 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Pharmafarm S.r.l.